SE509029C2 - Långtidsverkande diklofenak-natriumpreparat - Google Patents

Långtidsverkande diklofenak-natriumpreparat

Info

Publication number
SE509029C2
SE509029C2 SE8901593A SE8901593A SE509029C2 SE 509029 C2 SE509029 C2 SE 509029C2 SE 8901593 A SE8901593 A SE 8901593A SE 8901593 A SE8901593 A SE 8901593A SE 509029 C2 SE509029 C2 SE 509029C2
Authority
SE
Sweden
Prior art keywords
granules
long
diclofenac
acting
diclofenac sodium
Prior art date
Application number
SE8901593A
Other languages
English (en)
Swedish (sv)
Other versions
SE8901593D0 (sv
SE8901593L (sv
Inventor
Minoru Okada
Syuichi Kasai
Akira Iwasa
Original Assignee
Ss Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ss Pharmaceutical Co filed Critical Ss Pharmaceutical Co
Publication of SE8901593D0 publication Critical patent/SE8901593D0/xx
Publication of SE8901593L publication Critical patent/SE8901593L/
Publication of SE509029C2 publication Critical patent/SE509029C2/sv

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5036Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5026Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
SE8901593A 1988-08-16 1989-05-03 Långtidsverkande diklofenak-natriumpreparat SE509029C2 (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP20349888 1988-08-16

Publications (3)

Publication Number Publication Date
SE8901593D0 SE8901593D0 (sv) 1989-05-03
SE8901593L SE8901593L (sv) 1990-12-06
SE509029C2 true SE509029C2 (sv) 1998-11-30

Family

ID=16475153

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8901593A SE509029C2 (sv) 1988-08-16 1989-05-03 Långtidsverkande diklofenak-natriumpreparat

Country Status (13)

Country Link
US (1) US4968505A (fr)
JP (1) JPH07116028B2 (fr)
KR (1) KR950003610B1 (fr)
BE (1) BE1002710A5 (fr)
CA (1) CA1319616C (fr)
CH (1) CH678813A5 (fr)
DE (1) DE3915150C2 (fr)
FR (1) FR2635460B1 (fr)
GB (1) GB2221842B (fr)
HK (1) HK48194A (fr)
IT (1) IT1231517B (fr)
NL (1) NL194882C (fr)
SE (1) SE509029C2 (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2514078B2 (ja) * 1988-08-22 1996-07-10 エスエス製薬株式会社 圧縮成型製剤
US5079001A (en) * 1989-11-03 1992-01-07 Ciba-Geigy Corporation Liquid oral formulation of diclofenac
US5015481A (en) * 1990-05-03 1991-05-14 G. D. Searle & Co. Stabilized pharmaceutical admixture composition
JPH04230625A (ja) * 1990-12-27 1992-08-19 Standard Chem & Pharmaceut Corp Ltd 噴霧乾燥したジクロフェナクナトリウムを含み腸溶性の被覆を有するマイクロカプセルからなる微分散した錠剤組成物の製造方法
EP0520119A1 (fr) * 1991-06-17 1992-12-30 Spirig Ag Pharmazeutische Präparate Composition à base de diclofenac pour l'administration orale
US5518737A (en) * 1991-10-16 1996-05-21 Orion-Yhtyma Oy Peroral drug delivery system
WO1994003160A1 (fr) * 1992-08-05 1994-02-17 F.H. Faulding & Co. Limited Composition pharmaceutique sous forme de granules
JP3349535B2 (ja) * 1993-01-12 2002-11-25 フロイント産業株式会社 球形顆粒の製造方法
DE4403943A1 (de) 1994-02-08 1995-08-10 Hexal Pharma Gmbh Orale Azrneimittelzubereitung mit Diclofenac-Natrium
US6486177B2 (en) * 1995-12-04 2002-11-26 Celgene Corporation Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate
US5837284A (en) * 1995-12-04 1998-11-17 Mehta; Atul M. Delivery of multiple doses of medications
US5922736A (en) * 1995-12-04 1999-07-13 Celegene Corporation Chronic, bolus administration of D-threo methylphenidate
EP1690531A3 (fr) * 1996-09-30 2010-01-20 Alza Corporation Forme de dosage et méthode d'administration de médicament
CN1231603A (zh) * 1996-09-30 1999-10-13 阿尔萨公司 剂型和施药方法
US6919373B1 (en) 1996-11-12 2005-07-19 Alza Corporation Methods and devices for providing prolonged drug therapy
ES2129010B1 (es) * 1997-01-02 2000-01-16 Gold Oscar Composicion de accion prolongada en granulos que contienen 4-nitro-2- fenoximetansulfonanilida y su procedimiento de preparacion.
ES2129356B1 (es) * 1997-03-26 2000-01-16 Pierre Fabre Iberica S A Forma farmaceutica de liberacion prolongada y procedimiento para su o btencion.
US6312724B1 (en) 1997-04-04 2001-11-06 Isa Odidi Sustained release pharmaceutical matrix tablet of pharmaceutically acceptable salts of diclofenac and process for preparation thereof
US6962997B1 (en) * 1997-05-22 2005-11-08 Celgene Corporation Process and intermediates for resolving piperidyl acetamide steroisomers
EP1110553B1 (fr) * 1998-08-10 2013-03-27 Asahi Kasei Pharma Corporation Preparations orales, a liberation prolongee, a base de chlorhydrate de fasudil
EA200300128A1 (ru) * 2000-08-10 2003-08-28 Юнихарт Корпорейшн Фармацевтические композиции, содержащие карбонат лития
FR2842735B1 (fr) * 2002-07-26 2006-01-06 Flamel Tech Sa Microcapsules a liberation modifiee de principes actifs peu solubles pour l'administration per os
US20050239830A1 (en) * 2004-04-26 2005-10-27 Vikram Khetani Methods of diminishing co-abuse potential
AU2005313887B2 (en) * 2004-12-09 2011-10-27 Celgene Corporation Treatment using D-threo methylphenidate
WO2012169614A1 (fr) * 2011-06-10 2012-12-13 ニプロ株式会社 Procédé de production de comprimés orodispersibles
US8962020B2 (en) * 2012-07-26 2015-02-24 Glycadia Inc. Long-acting and controlled release formulations of 2-[(3-chlorophenyl) amino] phenylacetic acid
EP3377046A1 (fr) * 2015-11-17 2018-09-26 Rontis Hellas S.A. Composition pharmaceutique contenant un médicament anti-inflammatoire non stéroïdien et un inhibiteur de pompe à protons
CN114306260B (zh) * 2021-12-29 2023-10-24 濮阳市汇元药业有限公司 一种新型双氯芬酸钠片及其制备方法
DE202022100544U1 (de) 2022-01-31 2022-02-16 Ranjitsing Babasing Bayas Neue orale Streifen- oder Dünnfilmform von Diclofenac-Natrium

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2950977A1 (de) * 1978-12-22 1980-07-10 Donald E Panoz Neue galenische zubereitungsform fuer die orale verabreichung von medikamenten mit programmierter besetzung, sowie verfahren zu ihrer herstellung
FR2470599A1 (fr) * 1979-12-07 1981-06-12 Panoz Donald Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus
CH655507B (fr) * 1983-01-12 1986-04-30
DE3328401A1 (de) * 1983-08-05 1985-02-21 Merckle GmbH, 7902 Blaubeuren Injizierbare loesung zur behandlung von entzuendungen
IE56459B1 (en) * 1983-12-21 1991-08-14 Elan Corp Ltd Controlled absorption pharmaceutical formulation
DE3446873A1 (de) * 1984-12-21 1986-07-10 Merckle Gmbh Fluessige diclofenac-zubereitungen
CH664085A5 (de) * 1985-02-08 1988-02-15 Ciba Geigy Ag Pharmazeutische praeparate mit analgetischer wirksamkeit, sowie deren herstellung.
JPS61280426A (ja) * 1985-06-04 1986-12-11 Ikeda Mohandou:Kk 消炎鎮痛用貼付剤
US5188840A (en) * 1985-09-26 1993-02-23 Chugai Seiyaku Kabushiki Kaisha Slow-release pharmaceutical agent
IE63321B1 (en) * 1986-02-03 1995-04-05 Elan Corp Plc Drug delivery system
US4814183A (en) * 1987-08-31 1989-03-21 Merck & Co., Inc. Device for the controlled release of drugs with Donnan-like modulation by charged insoluble resins
CH675537A5 (fr) * 1988-03-25 1990-10-15 Ciba Geigy Ag

Also Published As

Publication number Publication date
JPH02237918A (ja) 1990-09-20
JPH07116028B2 (ja) 1995-12-13
CH678813A5 (fr) 1991-11-15
IT8948030A0 (it) 1989-06-01
NL8901200A (nl) 1990-03-16
DE3915150A1 (de) 1990-03-01
KR950003610B1 (ko) 1995-04-17
BE1002710A5 (fr) 1991-05-14
GB2221842B (en) 1991-10-16
GB2221842A (en) 1990-02-21
NL194882C (nl) 2003-06-04
IT1231517B (it) 1991-12-07
US4968505A (en) 1990-11-06
FR2635460B1 (fr) 1994-09-16
FR2635460A1 (fr) 1990-02-23
HK48194A (en) 1994-05-27
KR900002769A (ko) 1990-03-23
NL194882B (nl) 2003-02-03
GB8910271D0 (en) 1989-06-21
SE8901593D0 (sv) 1989-05-03
CA1319616C (fr) 1993-06-29
DE3915150C2 (de) 1997-04-17
SE8901593L (sv) 1990-12-06

Similar Documents

Publication Publication Date Title
SE509029C2 (sv) Långtidsverkande diklofenak-natriumpreparat
US5229135A (en) Sustained release diltiazem formulation
JP3157182B2 (ja) 一日一回投与のための吸収の制御されたナプロキセン配合物
CA1264296A (fr) Formules a trois niveaux distincts de liberation
US4828840A (en) Sustained-release formulation and production thereof
US4904476A (en) Formulations providing three distinct releases
US4794001A (en) Formulations providing three distinct releases
KR100812832B1 (ko) 다입자 변형 방출 조성물
US7771750B2 (en) Controlled release oral dosage form
US5196203A (en) Theophylline dosage form
US5186943A (en) Compressed-molded preparations
IE60313B1 (en) Sustained release pharmaceutical composition
HU214590B (hu) Eljárás ellenőrzött hatóanyag-felszabadítású gyógyszerkészítmények előállítására
US5277916A (en) Tetracycline dosage form
JP2003508430A (ja) トラマドールサッカリナートを含有する徐放性投薬形
AU2003246792A1 (en) Oral suspension of active principle microcapsules
NZ232030A (en) Sustained release pharmaceutical pellet composition; theophylline compound core, coated to allow faster release rate in intestine
HU204201B (en) Coating materialdetermining delivery of active components from pharmaceutical compositions, and process for producing phrmaceutical compositions containing this coating material
KR970001656B1 (ko) 조절흡수 딜티아젬 제제
WO2009002416A1 (fr) Formulation de chlorhydrate de tamsulosine à libération contrôlée
CA2433915C (fr) Forme posologique orale a liberation regulee amelioree
AU614328B2 (en) Tetracycline dosage form

Legal Events

Date Code Title Description
NUG Patent has lapsed